• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酸二酯酶抑制剂在女性性功能障碍治疗中的应用:范围综述。

The use of phosphodiesterase inhibitors in the treatment of female sexual dysfunction: scoping review.

机构信息

USF São Vicente Porto Portugal Family Medicine, USF São Vicente, Porto, Portugal.

USF Renascer Porto Portugal Family Medicine, USF Renascer, Porto, Portugal.

出版信息

Rev Bras Ginecol Obstet. 2024 Jul 26;46. doi: 10.61622/rbgo/2024rbgo49. eCollection 2024.

DOI:10.61622/rbgo/2024rbgo49
PMID:39176202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11341182/
Abstract

OBJECTIVE

The purpose of this study was to analyze the available evidence regarding the efficacy of iPDE5 in the treatment of female sexual dysfunction (FSD).

METHODS

A comprehensive literature search was conducted in March 2023 through the main scientific databases.

RESULTS

A total of 53 articles were identified, out of which, 6 met the predefined inclusion criteria. All of these were randomized controlled trials. Among the included studies, 4 demonstrated the effectiveness of sildenafil in improving sexual response and addressing FSD, while 2 studies failed to establish its efficacy in this context.

CONCLUSION

Overall, the efficacy of sildenafil in the treatment of FSD remains controversial and inconclusive based on the available evidence. Further research is necessary to clarify the therapeutic potential of iPDE5 in addressing FSD and to better understand the factors that influence treatment outcomes.

摘要

目的

本研究旨在分析 iPDE5 在治疗女性性功能障碍(FSD)方面的疗效的现有证据。

方法

2023 年 3 月,通过主要科学数据库进行了全面的文献检索。

结果

共确定了 53 篇文章,其中 6 篇符合预先设定的纳入标准。这些都是随机对照试验。在纳入的研究中,4 项研究表明西地那非在改善性反应和治疗 FSD 方面有效,而 2 项研究未能在这方面证实其疗效。

结论

根据现有证据,西地那非治疗 FSD 的疗效仍存在争议和不确定性。有必要进行进一步的研究,以阐明 iPDE5 在治疗 FSD 方面的治疗潜力,并更好地了解影响治疗结果的因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1507/11341182/08799b05c22b/1806-9339-rbgo-46-e-rbgo49-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1507/11341182/08799b05c22b/1806-9339-rbgo-46-e-rbgo49-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1507/11341182/08799b05c22b/1806-9339-rbgo-46-e-rbgo49-gf01.jpg

相似文献

1
The use of phosphodiesterase inhibitors in the treatment of female sexual dysfunction: scoping review.磷酸二酯酶抑制剂在女性性功能障碍治疗中的应用:范围综述。
Rev Bras Ginecol Obstet. 2024 Jul 26;46. doi: 10.61622/rbgo/2024rbgo49. eCollection 2024.
2
Use of sildenafil for female sexual dysfunction.西地那非用于女性性功能障碍
Ann Pharmacother. 2006 May;40(5):931-4. doi: 10.1345/aph.1G471. Epub 2006 Apr 18.
3
Systematic review and meta-analysis of phosphodiesterase type 5 inhibitors for the treatment of female sexual dysfunction.5型磷酸二酯酶抑制剂治疗女性性功能障碍的系统评价和荟萃分析。
Int J Gynaecol Obstet. 2016 May;133(2):139-45. doi: 10.1016/j.ijgo.2015.08.015. Epub 2015 Dec 17.
4
Assessing the clinical efficacy of sildenafil for the treatment of female sexual dysfunction.评估西地那非治疗女性性功能障碍的临床疗效。
Ann Pharmacother. 2009 Jul;43(7):1275-85. doi: 10.1345/aph.1L691. Epub 2009 Jun 9.
5
Strategies for managing sexual dysfunction induced by antidepressant medication.抗抑郁药物所致性功能障碍的管理策略。
Cochrane Database Syst Rev. 2013 May 31;2013(5):CD003382. doi: 10.1002/14651858.CD003382.pub3.
6
Sildenafil in postmenopausal women with sexual dysfunction.西地那非用于治疗性功能障碍的绝经后女性。
Urology. 1999 Sep;54(3):578-9.
7
Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction: Pharmacology and Clinical Impact of the Sildenafil Citrate Orodispersible Tablet Formulation.5型磷酸二酯酶抑制剂治疗勃起功能障碍:枸橼酸西地那非口腔崩解片剂型的药理学及临床影响
Clin Ther. 2017 Feb;39(2):370-377. doi: 10.1016/j.clinthera.2017.01.001. Epub 2017 Jan 28.
8
Sildenafil may improve sexual functioning in depressed women.西地那非可能改善抑郁女性的性功能。
Harv Ment Health Lett. 2008 Oct;25(4):7.
9
A literature review and case reports series on the use of phosphodiesterase inhibitors in the treatment of female sexual dysfunction.一篇关于磷酸二酯酶抑制剂用于治疗女性性功能障碍的文献综述及病例报告系列。
Int J STD AIDS. 2009 Mar;20(3):152-7. doi: 10.1258/ijsa.2008.008336.
10
The role of phosphodiesterase type 5 inhibitors in the management of premature ejaculation: a critical analysis of basic science and clinical data.5型磷酸二酯酶抑制剂在早泄治疗中的作用:基础科学与临床数据的批判性分析
Eur Urol. 2007 Nov;52(5):1331-9. doi: 10.1016/j.eururo.2007.08.005. Epub 2007 Aug 17.

本文引用的文献

1
Prevalence and Factors Associated with Female Sexual Dysfunction in Beijing, China.中国北京女性性功能障碍的患病率及相关因素
Chin Med J (Engl). 2017 Jun 20;130(12):1389-1394. doi: 10.4103/0366-6999.207466.
2
Phosphodiesterase inhibitors in clinical urology.磷酸二酯酶抑制剂在临床泌尿科中的应用。
Expert Rev Clin Pharmacol. 2013 May;6(3):323-32. doi: 10.1586/ecp.13.16.
3
Female sexual dysfunction among young and middle-aged women in Hong Kong: prevalence and risk factors.香港中青年女性性功能障碍:患病率及危险因素。
J Sex Med. 2012 Nov;9(11):2911-8. doi: 10.1111/j.1743-6109.2012.02773.x. Epub 2012 May 21.
4
Effect of sildenafil on clitoral blood flow and sexual response in postmenopausal women with orgasmic dysfunction.西地那非对患有性高潮功能障碍的绝经后女性阴蒂血流及性反应的影响。
Int J Gynaecol Obstet. 2008 Aug;102(2):115-9. doi: 10.1016/j.ijgo.2008.03.020. Epub 2008 Jun 26.
5
Prevalence and comorbidity of sexual dysfunctions in a Portuguese clinical sample.葡萄牙临床样本中性功能障碍的患病率及共病情况。
J Sex Marital Ther. 2006 Mar-Apr;32(2):173-82. doi: 10.1080/00926230500442334.
6
Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study.枸橼酸西地那非治疗女性性唤起障碍的安全性和有效性:一项双盲、安慰剂对照研究。
J Urol. 2003 Dec;170(6 Pt 1):2333-8. doi: 10.1097/01.ju.0000090966.74607.34.
7
Sexual psychophysiology and effects of sildenafil citrate in oestrogenised women with acquired genital arousal disorder and impaired orgasm: a randomised controlled trial.西地那非对患有获得性性唤起障碍和性高潮障碍的雌激素化女性的性心理生理学及影响:一项随机对照试验。
BJOG. 2003 Nov;110(11):1014-24.
8
Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder.枸橼酸西地那非治疗女性性唤起障碍相关性功能障碍的疗效与安全性。
J Womens Health Gend Based Med. 2002 May;11(4):367-77. doi: 10.1089/152460902317586001.
9
Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, cross-over, placebo-controlled study.用西地那非治疗受性唤起障碍影响的绝经前女性:一项双盲、交叉、安慰剂对照研究。
BJOG. 2001 Jun;108(6):623-8. doi: 10.1111/j.1471-0528.2001.00143.x.
10
Vasculogenic female sexual dysfunction: vaginal engorgement and clitoral erectile insufficiency syndromes.血管源性女性性功能障碍:阴道充血和阴蒂勃起功能不全综合征。
Int J Impot Res. 1998 May;10 Suppl 2:S84-90; discussion S98-101.